ERD

LIVERHOPE | SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS

01-01-2017

-

28-02-2023

Show more information

Organisation INNOVATION ACTA S.R.L.

LIVERAIM | A Biomarker-Based Platform for Early Diagnosis of Chronic Liver Disease to Enable Personalized Therapy

01-03-2024

-

28-02-2030

Show more information

Organisation INNOVATION ACTA S.R.L.

NECESSITY | NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients

01-01-2019

-

31-12-2025

Show more information

Organisation INNOVATION ACTA S.R.L.

GUIDE.MRD | GUIding multi-moDal thErapies against MRD by liquid biopsies - GUIDE.MRD

01-05-2023

-

30-04-2028

Show more information

Organisation INNOVATION ACTA S.R.L.

LiverScreen | Screening for liver fibrosis - population-based study across European countries

01-01-2020

-

30-06-2025

Show more information

Organisation INNOVATION ACTA S.R.L.

GlyCanDrug | A training network on the design of precision therapeutics that target key glycan motifs implicated in cancer

01-12-2023

-

30-11-2027

Show more information

Organisation INNOVATION ACTA S.R.L.

CohesiNet | Cohesin and its regulators: from chromosome dynamics and nuclear architecture to human diseases

01-01-2023

-

31-12-2026

Show more information

Organisation INNOVATION ACTA S.R.L.

HDM-FUN | Host directed medicine in invasive fungal infection

01-01-2020

-

31-12-2024

Show more information

Organisation INNOVATION ACTA S.R.L.

exTra | Innovative Applications of Extracorporeal Photopheresis in Solid Organ Transplantation

01-09-2023

-

31-08-2027

Show more information

Organisation INNOVATION ACTA S.R.L.

HIPGEN | Placenta-expanded adherent stromal cells (PLX-PAD) as an innovative therapy for improving recovery and survival following hip fracture arthroplasty – HIPGEN, a multicenter phase III trial

01-01-2018

-

30-09-2022

Show more information

Organisation INNOVATION ACTA S.R.L.

TOP-GUT | Training for Organoids modelling Physiology and Pathology in the human gastrointestinal tract

01-11-2023

-

31-10-2027

Show more information

Organisation INNOVATION ACTA S.R.L.

THRIVE | TUMOUR-HOST INTERACTIONS IN LIVER CANCER OF CHILDHOOD AND ADULTS

01-12-2023

-

30-11-2028

Show more information

Organisation INNOVATION ACTA S.R.L.

AUREUS | wAll teichoic acids as immUnogenic and conseRved altErnative targets for therapies versUs S. aureus

01-02-2025

-

31-01-2029

Show more information

Organisation INNOVATION ACTA S.R.L.

TOLERATE | An integrated approach to restore tolerance in autoimmune disease

01-10-2022

-

30-09-2026

Show more information

Organisation INNOVATION ACTA S.R.L.

GLYCO-N | GLYCOprotein N-glycosylation from non-life to eukaryotes: a Doctoral Network to expand the knowledge on a ubiquitous posttranslational modification of proteins

01-02-2024

-

31-01-2028

Show more information

Organisation INNOVATION ACTA S.R.L.

INTEGRATA | Integrating chemical and biological approaches to target NAD production and signaling in cancer

01-11-2018

-

30-04-2023

Show more information

Organisation INNOVATION ACTA S.R.L.

IMMUTOL | ADVANCED ANTIGEN-SPECIFIC DENDRITIC CELL-BASED THERAPY TO RE-ESTABLISH TOLERANCE IN IMMUNE-MEDIATED DISEASES

01-05-2023

-

30-04-2027

Show more information

Organisation INNOVATION ACTA S.R.L.

PACE | A multicenter phase IIb study using HLA-unmatched allogeneic placenta-derived stromal cells (PLX-PAD) for the treatment of severe critical limb ischemia accompanied by mechanistic studies

01-01-2017

-

31-12-2021

Show more information

Organisation INNOVATION ACTA S.R.L.

T-FITNESS | FINE-TUNING T CELL NETWORKS OF EXHAUSTION BY SYNTHETIC SENSORS

01-09-2022

-

31-08-2026

Show more information

Organisation INNOVATION ACTA S.R.L.

geneTIGA | Gene-edited T cells combating IgA Nephropathy. A blueprint approach for safe & efficient genome editing of T cells to sustainably combat several immune diseases and cancers related to B-cell pathology

01-07-2022

-

30-06-2026

Show more information

Organisation INNOVATION ACTA S.R.L.

RESHAPE | Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Generation regulatory T cell (Treg) Approaches – from Advanced Technology Developments to First-in-Human Trials

01-01-2019

-

31-12-2024

Show more information

Organisation INNOVATION ACTA S.R.L.

RESTORE | RESTORE Health by Advanced Therapies (Advanced Therapy Medicinal Products and Biologized Medical Devices) – ALL for Advanced Therapies – with Passion – For Patients

01-03-2019

-

31-07-2020

Show more information

Organisation INNOVATION ACTA S.R.L.

PROTO | PROTO - Advanced PeRsOnalized Therapies for Osteoarthritis – TACKLING INFLAMMATION TO IMPROVE PATIENT OUTCOMES

01-01-2023

-

31-12-2027

Show more information

Organisation INNOVATION ACTA S.R.L.

SECRET | Exploring the therapeutic potential of perinatal cell SECRETomes

01-09-2024

-

31-08-2028

Show more information

Organisation INNOVATION ACTA S.R.L.

B-specific | B-specific: B-cell related gene and protein markers with prognostic and therapeutic value for CVD

01-10-2023

-

30-09-2027

Show more information

Organisation INNOVATION ACTA S.R.L.

Projects overview

Selected filters:

LIVERHOPE | SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS

LIVERAIM | A Biomarker-Based Platform for Early Diagnosis of Chronic Liver Disease to Enable Personalized Therapy

NECESSITY | NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients

GUIDE.MRD | GUIding multi-moDal thErapies against MRD by liquid biopsies - GUIDE.MRD

LiverScreen | Screening for liver fibrosis - population-based study across European countries

GlyCanDrug | A training network on the design of precision therapeutics that target key glycan motifs implicated in cancer

CohesiNet | Cohesin and its regulators: from chromosome dynamics and nuclear architecture to human diseases

HDM-FUN | Host directed medicine in invasive fungal infection

exTra | Innovative Applications of Extracorporeal Photopheresis in Solid Organ Transplantation

HIPGEN | Placenta-expanded adherent stromal cells (PLX-PAD) as an innovative therapy for improving recovery and survival following hip fracture arthroplasty – HIPGEN, a multicenter phase III trial

TOP-GUT | Training for Organoids modelling Physiology and Pathology in the human gastrointestinal tract

THRIVE | TUMOUR-HOST INTERACTIONS IN LIVER CANCER OF CHILDHOOD AND ADULTS

AUREUS | wAll teichoic acids as immUnogenic and conseRved altErnative targets for therapies versUs S. aureus

TOLERATE | An integrated approach to restore tolerance in autoimmune disease

GLYCO-N | GLYCOprotein N-glycosylation from non-life to eukaryotes: a Doctoral Network to expand the knowledge on a ubiquitous posttranslational modification of proteins

INTEGRATA | Integrating chemical and biological approaches to target NAD production and signaling in cancer

IMMUTOL | ADVANCED ANTIGEN-SPECIFIC DENDRITIC CELL-BASED THERAPY TO RE-ESTABLISH TOLERANCE IN IMMUNE-MEDIATED DISEASES

PACE | A multicenter phase IIb study using HLA-unmatched allogeneic placenta-derived stromal cells (PLX-PAD) for the treatment of severe critical limb ischemia accompanied by mechanistic studies

T-FITNESS | FINE-TUNING T CELL NETWORKS OF EXHAUSTION BY SYNTHETIC SENSORS

geneTIGA | Gene-edited T cells combating IgA Nephropathy. A blueprint approach for safe & efficient genome editing of T cells to sustainably combat several immune diseases and cancers related to B-cell pathology

RESHAPE | Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Generation regulatory T cell (Treg) Approaches – from Advanced Technology Developments to First-in-Human Trials

RESTORE | RESTORE Health by Advanced Therapies (Advanced Therapy Medicinal Products and Biologized Medical Devices) – ALL for Advanced Therapies – with Passion – For Patients

PROTO | PROTO - Advanced PeRsOnalized Therapies for Osteoarthritis – TACKLING INFLAMMATION TO IMPROVE PATIENT OUTCOMES

SECRET | Exploring the therapeutic potential of perinatal cell SECRETomes

B-specific | B-specific: B-cell related gene and protein markers with prognostic and therapeutic value for CVD